Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 15, Issue 10, Pages 1244
Publisher
MDPI AG
Online
2022-10-11
DOI
10.3390/ph15101244
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Implantable Sandwich-like Scaffold/Fiber Composite Spatiotemporally Releasing Combretastatin A4 and Doxorubicin for Efficient Inhibition of Postoperative Tumor Recurrence
- (2022) Youqiang Fang et al. ACS Applied Materials & Interfaces
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB Dependencies
- (2021) Yi Liang et al. CLINICAL CANCER RESEARCH
- 3D Printed Bioceramic Scaffolds as a Universal Therapeutic Platform for Synergistic Therapy of Osteosarcoma
- (2021) Wentao Dang et al. ACS Applied Materials & Interfaces
- Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention
- (2021) Maria Teresa Vietri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Engineering Microneedle Patches for Improved Penetration: Analysis, Skin Models and Factors Affecting Needle Insertion
- (2021) Pooyan Makvandi et al. Nano-Micro Letters
- Prostate cancer
- (2021) Shahneen Sandhu et al. LANCET
- Synergy in Nanomedicine: What It Is Not, and What It Might Be
- (2021) Steven J. Staffa et al. NANO LETTERS
- Salvage therapy for prostate cancer after radical prostatectomy
- (2021) Nicholas G. Zaorsky et al. Nature Reviews Urology
- Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression
- (2021) Milad Ashrafizadeh et al. CARBOHYDRATE POLYMERS
- Hemin particles-functionalized 3D printed scaffolds for combined photothermal and chemotherapy of osteosarcoma
- (2021) Wentao Dang et al. CHEMICAL ENGINEERING JOURNAL
- Dual targeting of CDK4/6 and BCL2 pathways augments tumor response in estrogen receptor positive breast cancer
- (2020) James R Whittle et al. CLINICAL CANCER RESEARCH
- Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies
- (2020) Farshad Moradi Kashkooli et al. JOURNAL OF CONTROLLED RELEASE
- Cell Death in the Origin and Treatment of Cancer
- (2020) Andreas Strasser et al. MOLECULAR CELL
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer
- (2020) Philip Cornford et al. EUROPEAN UROLOGY
- Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
- (2019) Jiajia Xue et al. CHEMICAL REVIEWS
- Advances in drug delivery for post-surgical cancer treatment
- (2019) Lin-Lin Bu et al. BIOMATERIALS
- A Time‐Programmed Release of Dual Drugs from an Implantable Trilayer Structured Fiber Device for Synergistic Treatment of Breast Cancer
- (2019) Xilin Li et al. Small
- Combretastatin A4 Nanodrug‐Induced MMP9 Amplification Boosts Tumor‐Selective Release of Doxorubicin Prodrug
- (2019) Jian Jiang et al. ADVANCED MATERIALS
- Electrospun Nanofibers for Drug Delivery and Biosensing
- (2019) Conor Cleeton et al. ACS Biomaterials-Science & Engineering
- Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies
- (2018) Jill A. Gallaher et al. CANCER RESEARCH
- Adjuvant Chemotherapy for Prostate Cancer: The Long and Winding Road
- (2018) Bruce Montgomery et al. EUROPEAN UROLOGY
- Chemotherapy medication errors
- (2018) Saul N Weingart et al. LANCET ONCOLOGY
- Selective targeting of antiapoptotic BCL-2 proteins in cancer
- (2018) Ahmet Can Timucin et al. MEDICINAL RESEARCH REVIEWS
- Multifunctional Electrospun Nanofibers for Enhancing Localized Cancer Treatment
- (2018) Yike Fu et al. Small
- Recent Progress in Coaxial Electrospinning: New Parameters, Various Structures, and Wide Applications
- (2018) Jihyun Yoon et al. ADVANCED MATERIALS
- Glucose feeds the TCA cycle via circulating lactate
- (2017) Sheng Hui et al. NATURE
- From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
- (2017) Avi Ashkenazi et al. NATURE REVIEWS DRUG DISCOVERY
- Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges
- (2017) Nicholas L. Syn et al. TRENDS IN BIOTECHNOLOGY
- An Implantable Active-Targeting Micelle-in-Nanofiber Device for Efficient and Safe Cancer Therapy
- (2015) Guang Yang et al. ACS Nano
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Doxorubicin-loaded electrospun poly(l-lactic acid)/mesoporous silica nanoparticles composite nanofibers for potential postsurgical cancer treatment
- (2013) Kexin Qiu et al. Journal of Materials Chemistry B
- Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
- (2011) Leena Gandhi et al. JOURNAL OF CLINICAL ONCOLOGY
- Electrospinning: A fascinating fiber fabrication technique
- (2010) Nandana Bhardwaj et al. BIOTECHNOLOGY ADVANCES
- The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer
- (2008) Roberto Petrioli et al. CANCER TREATMENT REVIEWS
- Ultrafine PEG–PLA fibers loaded with both paclitaxel and doxorubicin hydrochloride and their in vitro cytotoxicity
- (2008) Xiuling Xu et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started